Min Luo

2.4k citations
25 papers · 2.0k indexed · 2 hit papers · h-index 16
Topics
interferon and immune responses (10 papers)Immunotherapy and Immune Responses (10 papers)Cancer Immunotherapy and Biomarkers (7 papers)

In The Last Decade

Min Luo

24 papers receiving 2.0k citations

Hit Papers

A STING-activating nanovaccine for cancer immunotherapy201720262020202320172021250500750

Peers

Min Luo
Comparison fields: 5 of 95
  • Immunology 1.2k
  • Molecular Biology 820
  • Biomedical Engineering 786
  • Oncology 427
  • Biomaterials 289
Replace Ying‐Li Luo with:
Ying‐Li Luo China
Meir Goldsmith Israel
Chao Wan China
Sean A. Dilliard United States
Ashish Kulkarni United States
Flávia Castro Portugal
Junhua Mai United States
Joshua C. Doloff United States
Yeonsun Hong South Korea
Min Luo relative to Ying‐Li Luo China Ying‐Li Luo's profile →
Citations per field
00.5×2.8×
Ying‐Li Luo · 1×
Citations per year

Countries citing papers authored by Min Luo

Since Specialization
Citations

This map shows the geographic impact of Min Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Luo more than expected).

Fields of papers citing papers by Min Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Luo. The network helps show where Min Luo may publish in the future.

Co-authorship network of co-authors of Min Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Min Luo. A scholar is included among the top collaborators of Min Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min Luo. Min Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4 1
5 1
6 44
7 35
8 5
9 93
10
Prolonged activation of innate immune pathways by a polyvalent STING agonistbreakdown →
240
11 40
12 27
13 31
14 38
15 1
16 83
17 224
18
A STING-activating nanovaccine for cancer immunotherapybreakdown →
752
19 102
20 120

About Min Luo

Min Luo is a scholar working on Immunology, Aging and Oncology, having authored 25 papers that have together received 2.0k indexed citations. Recurring topics across this work include interferon and immune responses (10 papers), Immunotherapy and Immune Responses (10 papers) and Cancer Immunotherapy and Biomarkers (7 papers). The work is most often cited by research in Immunology (1.2k citations), Biomaterials (289 citations) and Biomedical Engineering (786 citations). Min Luo has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jinming Gao, Zhaohui Wang, Zhijian J. Chen, Yang-Xin Fu, Yang Li, Gang Huang, Jayanthi Lea, Chensu Wang, Hua Wang and Matthew R. Porembka. Their work appears in journals such as Journal of the American Chemical Society, Advanced Materials and Angewandte Chemie International Edition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026